TREATMENT OF MOPP-RESISTANT HODGKINS-DISEASE (HD) WITH ADRIAMYCIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE (ABVD)

被引：0
|
作者：
SANTORO, A [1 ]
MONFARDINI, S [1 ]
BONADONNA, G [1 ]
机构：
[1] IST NAZL TUMORI,I-20133 MILAN,ITALY
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [41] LONG-TERM FOLLOW-UP WITH ABDIC SALVAGE CHEMOTHERAPY OF MOPP-RESISTANT HODGKINS-DISEASE
    TANNIR, N
    HAGEMEISTER, F
    VELASQUEZ, W
    CABANILLAS, F
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (07) : 432 - 439
  • [42] COMBINATION CHEMOTHERAPY IN MOPP RESISTANT HODGKINS-DISEASE
    LOH, KK
    GAMBLE, JF
    SHULLENBERGER, CC
    FULLER, LM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 267 - 267
  • [43] COMBINATION CHEMOTHERAPY WITH ALTERNATING MOPP-ABVD IN ADVANCED HODGKINS-DISEASE
    BRUSAMOLINO, E
    LAZZARINO, M
    MORRA, E
    INVERARDI, D
    MERANTE, S
    CASTELLI, G
    CANEVARI, A
    DORNINI, G
    BERNASCONI, C
    HAEMATOLOGICA, 1989, 74 (02) : 173 - 179
  • [44] CHEMOTHERAPY OF HODGKINS-DISEASE - MOPP PROTOCOL, ABVD PROTOCOL, CYCLOPHOSPHAMIDE AND MUSTARGEN
    PFLUGER, KH
    INTERNIST, 1992, 33 (06): : 446 - 447
  • [45] Incidence and Predictors of Bleomycin Pulmonary Toxicity in Hodgkin Lymphoma (HL) Patients Treated with Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD)
    Sun, Haowei
    Atenafu, Eshetu
    Tsang, Richard
    Kukreti, Vishal
    Crump, Michael
    Kuruvilla, John
    BLOOD, 2011, 118 (21) : 1556 - 1556
  • [46] COMBINATION CHEMOTHERAPY (CC) (MOPP, SANDWICH, MOPP/ABVD AND OPPA IN TURKISH CHILDREN WITH HODGKINS-DISEASE
    CAVDAR, AO
    GOZDASOGLU, S
    BABACAN, E
    UNAL, E
    YAVUZ, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 338 - 338
  • [47] ETOPOSIDE, VINBLASTINE, AND DOXORUBICIN - AN ACTIVE REGIMEN FOR THE TREATMENT OF HODGKINS-DISEASE IN RELAPSE FOLLOWING MOPP
    CANELLOS, GP
    PETRONI, GR
    BARCOS, M
    DUGGAN, DB
    PETERSON, BA
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 2005 - 2011
  • [48] INFLUENCE OF MOPP DOSES AND TIMING ON TREATMENT OUTCOME IN ADVANCED HODGKINS-DISEASE (HD)
    CARDE, P
    MACKINTOSH, FR
    ROSENBERG, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 512 - 512
  • [49] BLEOMYCIN, VELBAN, ADRIAMYCIN AND PREDNISONE (B-VAP) IN ADVANCED RESISTANT NON-HODGKINS LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD)
    STEINBERG, D
    SPARKS, JT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 56 - 56
  • [50] ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE
    BONADONNA, G
    SANTORO, A
    CANCER TREATMENT REVIEWS, 1982, 9 (01) : 21 - 35
12345